Ausio header

 

Presentations

 

 
   

16 October 2010

Presentation at the 9th International Symposium on the Role of Soy in Health Promotion and Chronic Disease Prevention and Treatment
Washington, DC

Development of AUS-131 (S-equol) as an Oral Agent for Menopausal Symptoms and Benign Prostatic Hyperplasia

 

8 October 2010

 

Presentation of results from two Phase 1 trials at The North American Menopause Society 21st Annual Meeting
Chicago, IL

Development of S-equol, a Natural, Selective Estrogen Receptor β (ERβ) Agonist for the Treatment of Menopausal Symptoms

 

25 January 2010

 

Presentation at the 7th Annual BIO Asia International Partnering Conference
Tokyo, Japan

Overview of Ausio Pharmaceuticals Technology and Partnering Strategy

 

22 June 2009

Presentation of preclinical data for AUS-131 at the Endocrinology Society Annual Meeting
Washington D.C.

S-equol Prevents Hot Flushes and Prostate Hypertrophy in Animal Models

 

19 May 2009

Presentation at Bio 2009 International Convention
Atlanta, Georgia

Development of a First-in-Class Selective Estrogen Receptor-β Agonist AUS-131

 

10 NOVEMBER 2008


Presentation at the 8th International Symposium on the Role of Soy in Health Promotion and Chronic Disease Prevention and Treatment
Tokyo, Japan

S-equol: Preclinical Studies Supporting its Use as a Pharmaceutical Agent

25 July 2008

Presentation at the 2nd Polyphenol Meeting
Tokyo, Japan

Recent Progress of Equol Science

Home Contact UsDirections